« Back to Record
Citation APA

Tré-Hardy, M., Cupaiolo, R., Wilmet, A., Antoine-Moussiaux, T., Coman-Vlagea, N., Della Vecchia, A., Horeanga, A., Papleux, E., Vekemans, M., Beukinga, I., & Blairon, L. (2022). Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected. The Journal of infection, 84(4), e31-e33. doi:10.1016/j.jinf.2022.02.009


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/344412

Tré-Hardy, M., Cupaiolo, R., Wilmet, A., Antoine-Moussiaux, T., Coman-Vlagea, N., Della Vecchia, A., Horeanga, A., Papleux, E., Vekemans, M., Beukinga, I., & Blairon, L. (2022). Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected. The Journal of infection, 84(4), e31-e33. doi:10.1016/j.jinf.2022.02.009